References
- Archer GT. Erythrophagocytosis. Mod Med Aust 1964;7:55.
- Archer GT. Phagocytosis by human monocytes of red cells coated with antibodies. Vox Sang 1965;10:590–8.
- Cline MJ, Lehrer RI. Phagocytosis by human monocytes. Blood 1968;32:423.
- Stevens JO, Schanfield MS, Braley JF. Detection of clinically signifcant IgG antibodies by an in vitro human peritoneal macrophage phagocytosis assay (abstract). Transfusion 1976;16:523.
- Schanfeld MS, Bauman D, Stevens JO. The detection of clinically signifcant “low avidity” erythrocyte alloantibodies by human macrophage assay. Transfusion 1978;10:382.
- Schanfeld MS, Schoeppner SL, Stevens JO. New approaches to detecting clinically signifcant antibodies in the laboratory. In: Sandler SG, Nusbacher J, Schanfeld MS, Eds. Immunobiology of the erythrocyte. New York: Alan Liss, 1980:305–23.
- Hunt JS, Beck ML, Hardman JT, Tegtmeier GE, Bayer WI. Characterization of human erythrocyte alloantibodies by IgG subclass and monocyte interaction. Am J Clin Pathol 198 0;74:259 –6 4.
- Hunt JS, Beck ML, Wood GW. Monocyte-mediated erythrocyte destruction: a comparative study of current methods. Transfusion 1981;21:735–8.
- Schanfeld MS, Stevens JO, Bauman D. The detection of clinically signifcant erythrocyte alloantibodies using a human mononuclear phagocyte assay. Transfusion 1981;21:571–6.
- Schoeppner-Esty S, Wahl T, Zawisza J, Mallory D, Davey R. Stimulation of antibody following transfusion of red cells during 51chromium survival studies. Blood 1986;68:302a.
- Schoeppner-Esty S, Chin J, Mallory D, Davey R. A comparison of the monocyte monolayer (MMA) to the 51chromium red cell survival for determining the clinical signifcance of red cell alloantibodies. Blood 1986;68:302a.
- Eckrich RJ, Mallory DM, Sandler SG. Correlation of monocyte monolayer assays and posttransfusion survival of Yt(a+) red cells in patients with anti-Yta. Immunohematology 1995;11: 81–4.
- Byrne PC, Eckrich RJ, Malamut DC, Mallory DM, Sandler SG. Use of the monocyte monolayer assay (MMA) to predict the clinical signifcance of anti-Cra (abstract). Transfusion 1995;35:61S.
- Garratty G. Predicting the clinical signifcance of alloantibodies and determining the in vivo survival of transfused red cells. In: Judd WJ, Barnes A, Eds. Clinical and serologic aspects of transfusion reactions. Arlington, VA: AABB, 1982:91–119.
- Garratty G, Nance S, O’Neill P. Correlation of monocyte monolayer assays and RBC survival in patients with allo-antibodies of questionable clinical signifcance. Transfusion 198 5;2 5:474.
- Garratty G, Nance S, O’Neill P. Factors that afect interpretation of monocyte monolayer assays. Transfusion 1986;26:570.
- Nance S, Arndt P, Garratty G. Predicting the signifcance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:4 49–52.
- Nance SJ, Arndt PA, Garratty G. The efect of fresh serum on monocyte monolayer reactivity. Transfusion 1988;28:398–9.
- Levy GJ, Selset G, McQuiston D, et al. Clinical signifcance of anti-Ytb: report of a case using a 51chromium red cell survival study. Transfusion 1988;28:265–7.
- Garratty G. Predicting the clinical signifcance of red cell antibodies with in vitro cellular assays. Trans Med Rev 1990;4:297–312.
- Nance S. Review: measuring red cell survival and determining the clinical signifcance of red cell antibodies. Immunohematology 1995;11:31–8.
- Lucas GF, Hadley SG, Nance SJ, Garratty G. Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test. Transfusion 1993;33:484–7.
- Nance S, Nelson J, O’Neill P, Garratty G. Correlation of monocyte monolayer assays, maternal antibody titers, and clinical course in hemolytic disease of the newborn (HDN) (abstract). Transfusion 1984;24:415.
- Nance S, Nelson J, Horenstein J, O’Neill P, Garratty G. Predictive value of amniocentesis versus monocyte monolayer assays in pregnant women with Rh antibodies (abstract). Transfusion 1986;26:570.
- Nance SJ, Nelson JM, Horenstein J, Amdt PA, Platt LD, Garratty G. Monocyte monolayer assay: an efcient noninvasive technique for predicting the severity of hemolytic disease of the newborn. Am J Clin Pathol 1989;92:89–92.
- Mollison PL. Results of tests with diferent cellular bioassays in relation to severity of RhD haemolytic disease: report from nine collaborating laboratories. Vox Sang 1991;60:225–9.
- Hadley AG, Kumpel BM, Leader KA, Poole GD, Fraser ID. Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn. Br J Haematol 1991;77:221–8.
- Arndt PA, Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical signifcance of blood group alloantibodies. Transfusion 2004;44:1273–81.
- Nance SJ, Arndt P. What to do when all RBCs are incompatible: serological aspects. Immunohematology 2004;3:147–60.
- Church A, Mallory D, Kavitsky D, Nance S. Impact of complement in the monocyte monolayer assay (abstract). Transfusion 1997;37(Suppl):27S.
- Maurer J, Kavitsky DM, Meny G, Nance S. Monocyte monolayer assay (MMA) to predict clinical signifcance of RBC alloantibodies: an update. Transfusion 2011;51(Suppl):171A.
- Keller MA, Nickle P, Mansfeld P, et al. Use of monocyte monolayer assay in a patient with anti-hrS and -Hr. Transfusion 2017;57(S 3) : 3 6 A.
- Nance S. A review of the in vitro methods to predict the clinical signifcance of red cell alloantibodies. Immunohematology 2018;34:11–5.
- Maurer J, Nance S, Nickle P. Relationship of antibody reactivity strength to reactivity in the monocyte monolayer assay (MMA). Transfusion 2018;58:187A.
- Maurer J, Nance S, Nickle P. Monocyte monolayer assay (MMA) to predict clinical signifcance of alloantibodies: a 22 year review. Transfusion 2018;58:103A.
- Flickinger C. In search of red blood cells for alloimmunized patients with sickle cell disease. Immunohematology 2006;22:136–42.
- Nance S, Scharberg EA, Thornton N, Yahalom V, Lomas-Francis C. International rare donor panels: a review. Vox Sang 2016;110:209–18.
- Seltsam A, Wagner FF, Salama A, et al. Antibodies to high frequency antigens may decrease the quality of transfusion support: an observational study. Transfusion 2003;43:1563–6.
- Branch DR, Gallagher MT, Mison AP, Sy Siok Hian AL, Petz LD. In vitro determination of red cell alloantibody signifcance using an assay of monocyte-macrophage interaction with sensitized erythrocytes. Br J Haematol 1984;56:19–29.
- Branch DR, Gallagher MT. Correlation of in vivo alloantibody signifcance or insignifcance with an in vitro monocyte-macrophage phagocytosis assay. Br J Haematol 1986;62: 783–5.
- Branch DR, Gallagher MT. Red blood cell mononuclear phagocyte assay. Vox Sang 1985;48:323–4.
- Branch DR, Gallagher MT. The importance of CO2 in short-term monocyte-macrophage assays. Transfusion 1985;25: 399–400.
- Tong TK, Cen S, Branch DR. The monocyte monolayer assay: past, present and future. Transfus Med Rev 2019;33:24–8.
- Kipkeu BJ, Shyian ML, da Silveira Cavalcante L, et al. Evaluation of the functional properties of cryopreserved bufy coat–derived monocytes for monocyte monolayer assay. Transfusion 2018;58:2027–35.
- Brojer E, Zupanska B, Michalewaks B. Adherence to human monocytes of red cells from autoimmune haemolytic anaemia and red cells sensitized with alloantibodies. Haematologia (Budap) 1982;15:135–45.
- Zupanska B, Thompson E, Brojer E, Merry AH. Phagocytosis of erythrocytes sensitized with known amounts of IgG1 and IgG3 anti-Rh antibodies. Vox Sang 1987;53:96–101.
- Zupanska B, Brojer E, Richards Y, Lenkiewicz B, Seyfried H, Howell P. Serological and Immunological characteristics of maternal anti-Rh(D) antibodies in predicting severity of haemolytic disease of the newborn. Vox Sang 1989;56:247–53.
- Zupanska B, Brojer E, McIntosh J, Seyfried H, Howell P. Correlation of monocyte-monolayer assay results, number of erythrocyte-bound IgG molecules, and IgG subclass composition in the study of red cell alloantibodies other than D. Vox Sang 1990;58:276–80.
- Zupanska B, Gronkowska A, Zimeski M. Comparison of activity of peripheral monocytes and splenic macrophages in the monocyte monolayer assay. Vox Sang 1995;68:241–2.
- Zupanska B. Assays to predict the clinical signifcance of blood group antibodies. Curr Opin Hematol 1998;5:412–6.
- Baldwin ML, Ness PM, Barrasso C, et al. In vivo studies of the long-term 51Cr red cell survival of serologically incompatible red cell units. Transfusion 1985;25:34–8.
- Wren MR, Issitt PD. The monocyte monolayer assay and in vivo antibody activity (abstract). Transfusion 1986;26:548.
- Issitt PD, Gutgsell NS, Hervis L. Some stored antibodies give unreliable results in the monocyte monolayer assay. Transfusion 1988;28:399–400.
- Gutgsell NS, Issitt LA, Issitt PD. Transfusion of antigen-positive, serologically-incompatible blood in immunized patients, based solely on the results of a monocyte monolayer assay (MMA) (abstract). Transfusion 1988;28:32S.
- Fabron A Jr, Baleotti W Jr, de Mello AB, et al. Application of noninvasive phagocytic cellular assays using autologous monocytes to assess red cell alloantibodies in sickle cell patients. Transfus Apher Sci 2004;31:29–35.
- Noumsi GT, Billingsley KL, Moulds JM. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay. Transfus Med 2015;25:92–100.
- El-sayed HAN, Abdollah MRA, Raafat SN, Ragab D. Monocyte monolayer assay in pre-transfusion testing: a magic key in transfusing patients with recurrent bad cross-match due to alloimmunization. J Immunol Methods 2021;492:112968.
- Bromilow IM, Duguid JK. Monocyte monolayer assay, autoanalyser values, and haemolytic disease of the newborn (letter). Br J Haematol 1991;78:588.
- Brown SJ, Perkins JT, Sosler SD, Hesketh D, Moise KJ. The monocyte-monolayer assay does not predict severity of hemolytic disease of the newborn (abstract). Transfusion 1991;31(Suppl):53S.
- Balola AHA, Mayer B, Bartolmäs T, Salama A. A fuorometric erythrophagocytosis assay using diferentiated monocytic THP-1 cells to assess the clinical signifcance of antibodies to red blood cells. Vox Sang 2021;116:1106–16.
- Nance S, Scandone P, Fassl L, et al. Monocyte monolayer assay (MMA) results are afected by transfusion of incompatible red cells (abstract). Transfusion 1997;37(Suppl):37S.
- Branch DR, Sandhu G, Raos M. Monocyte monolayer predictions of clinical outcome for serologically incompatible red blood cells is all about timing. Transfusion 2021;61: 2516–7.
- Nance S. Optimizing the use of limited rare red cells for hematopoietic cell transplant recipients. Transfusion 2007;47: 75 4 –7.
- Garratty G. Advances in red blood cell Immunology 1960 to 2009. Transfusion 2010;50:526–35.
- Meny G. Review: transfusing incompatible RBCs: clinical aspects. Immunohematology 2004;20:161–6.